Idenix Pharmaceuticals LLC;Università Degli Studi di Cagliari
发明人:
申请号：
EP01941564.5
公开号：
EP1292603B1
申请日:
2001.05.23
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
The present invention provides pharmaceutical compositions for the treatment of a hepatitis C infection in a host, comprising an antivirally effective amount of a 2'-C-branched nucleoside or a 2'-C-branched ribofuranosyl nucleoside, or pharmaceutically acceptable salts or esters thereof, in combination with one or more other anti-HCV agent. The present invention further provides the use of a 2'-C-branched nucleoside or a 2'-C-branched ribofuranosyl nucleoside, or pharmaceutically acceptable salts or esters thereof, in the manufacture of a medicament for the treatment of a hepatitis C infection in a host.
